Page last updated: 2024-11-03

pyrilamine and Carcinoma, Hepatocellular

pyrilamine has been researched along with Carcinoma, Hepatocellular in 1 studies

Pyrilamine: A histamine H1 antagonist. It has mild hypnotic properties and some local anesthetic action and is used for allergies (including skin eruptions) both parenterally and locally. It is a common ingredient of cold remedies.
mepyramine : An ethylenediamine derivative that is ethylenediamine in which one of the amino nitrogens is substituted by two methyl groups and the remaining amino nitrogen is substituted by a 4-methoxybenzyl and a pyridin-2-yl group.

Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheng, JS1
Lee, KC1
Wang, JL1
Tseng, LL1
Chou, KJ1
Tang, KY1
Jan, CR1

Other Studies

1 other study available for pyrilamine and Carcinoma, Hepatocellular

ArticleYear
Histamine-Induced increases in intracellular free Ca2+ levels in hepatoma cells.
    The Chinese journal of physiology, 2000, Dec-31, Volume: 43, Issue:4

    Topics: Biological Transport; Calcium; Carcinoma, Hepatocellular; Cimetidine; Cytosol; Extracellular Space;

2000